346 related articles for article (PubMed ID: 18630736)
1. Plasma-derived microparticles for biomarker discovery.
Smalley DM; Ley K
Clin Lab; 2008; 54(3-4):67-79. PubMed ID: 18630736
[TBL] [Abstract][Full Text] [Related]
2. Biomarker discovery from the plasma proteome using multidimensional fractionation proteomics.
Lee HJ; Lee EY; Kwon MS; Paik YK
Curr Opin Chem Biol; 2006 Feb; 10(1):42-9. PubMed ID: 16418010
[TBL] [Abstract][Full Text] [Related]
3. Recent progress in selected reaction monitoring MS-driven plasma protein biomarker analysis.
Chiu CL; Randall S; Molloy MP
Bioanalysis; 2009 Jul; 1(4):847-55. PubMed ID: 21083142
[TBL] [Abstract][Full Text] [Related]
4. Biomarker discovery from body fluids using mass spectrometry.
Villar-Garea A; Griese M; Imhof A
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Apr; 849(1-2):105-14. PubMed ID: 17097359
[TBL] [Abstract][Full Text] [Related]
5. Combination of abundant protein depletion and multi-lectin affinity chromatography (M-LAC) for plasma protein biomarker discovery.
Plavina T; Wakshull E; Hancock WS; Hincapie M
J Proteome Res; 2007 Feb; 6(2):662-71. PubMed ID: 17269723
[TBL] [Abstract][Full Text] [Related]
6. Proteomic technologies for the identification of disease biomarkers in serum: advances and challenges ahead.
Ray S; Reddy PJ; Jain R; Gollapalli K; Moiyadi A; Srivastava S
Proteomics; 2011 Jun; 11(11):2139-61. PubMed ID: 21548090
[TBL] [Abstract][Full Text] [Related]
7. Approaches to dimensionality reduction in proteomic biomarker studies.
Hilario M; Kalousis A
Brief Bioinform; 2008 Mar; 9(2):102-18. PubMed ID: 18310106
[TBL] [Abstract][Full Text] [Related]
8. Advances in proximal fluid proteomics for disease biomarker discovery.
Teng PN; Bateman NW; Hood BL; Conrads TP
J Proteome Res; 2010 Dec; 9(12):6091-100. PubMed ID: 21028795
[TBL] [Abstract][Full Text] [Related]
9. Protein biomarker discovery and validation: the long and uncertain path to clinical utility.
Rifai N; Gillette MA; Carr SA
Nat Biotechnol; 2006 Aug; 24(8):971-83. PubMed ID: 16900146
[TBL] [Abstract][Full Text] [Related]
10. Clinical proteomics: the promises and challenges of mass spectrometry-based biomarker discovery.
deVera IE; Katz JE; Agus DB
Clin Adv Hematol Oncol; 2006 Jul; 4(7):541-9. PubMed ID: 17147241
[TBL] [Abstract][Full Text] [Related]
11. On the development of plasma protein biomarkers.
Surinova S; Schiess R; Hüttenhain R; Cerciello F; Wollscheid B; Aebersold R
J Proteome Res; 2011 Jan; 10(1):5-16. PubMed ID: 21142170
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in atherosclerosis-based proteomics: new biomarkers and a future perspective.
Alvarez-Llamas G; de la Cuesta F; Barderas ME; Darde V; Padial LR; Vivanco F
Expert Rev Proteomics; 2008 Oct; 5(5):679-91. PubMed ID: 18937558
[TBL] [Abstract][Full Text] [Related]
13. Sample preparation and fractionation for proteome analysis and cancer biomarker discovery by mass spectrometry.
Ahmed FE
J Sep Sci; 2009 Mar; 32(5-6):771-98. PubMed ID: 19219839
[TBL] [Abstract][Full Text] [Related]
14. Overcoming the dynamic range problem in mass spectrometry-based shotgun proteomics.
Wu L; Han DK
Expert Rev Proteomics; 2006 Dec; 3(6):611-9. PubMed ID: 17181475
[TBL] [Abstract][Full Text] [Related]
15. Mass spectrometry-based biomarker discovery.
Zhou W; Petricoin EF; Longo C
Methods Mol Biol; 2012; 823():251-64. PubMed ID: 22081350
[TBL] [Abstract][Full Text] [Related]
16. Plasma proteomics: a noninvasive window on pathology and pediatric cardiac surgery.
Lull ME; Freeman WM; Myers JL; Midgley F; Kimatian SJ; Undar A; Vrana KE
ASAIO J; 2006; 52(5):562-6. PubMed ID: 16966860
[TBL] [Abstract][Full Text] [Related]
17. A proof-of-principle gel-free proteomics strategy for the identification of predictive biomarkers for the onset of pre-eclampsia.
Blankley RT; Gaskell SJ; Whetton AD; Dive C; Baker PN; Myers JE
BJOG; 2009 Oct; 116(11):1473-80. PubMed ID: 19663911
[TBL] [Abstract][Full Text] [Related]
18. Clinical application of urinary proteomics/peptidomics.
Albalat A; Mischak H; Mullen W
Expert Rev Proteomics; 2011 Oct; 8(5):615-29. PubMed ID: 21999832
[TBL] [Abstract][Full Text] [Related]
19. High-performance proteomics as a tool in biomarker discovery.
Meyer HE; Stühler K
Proteomics; 2007 Sep; 7 Suppl 1():18-26. PubMed ID: 17893859
[TBL] [Abstract][Full Text] [Related]
20. Mass spectrometry-coupled techniques for viral-related disease biomarker identification.
Rhea JM; Diwan CA; Molinaro RJ
Biomark Med; 2010 Dec; 4(6):859-70. PubMed ID: 21133707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]